secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2024-05-13T23:59:59+00:00
Accession:  0001104659-24-060235
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Collegium executes $35M accelerated share repurchase with Jefferies; initial 888,889 shares delivered
--------------------------------------------------------------------------------

- ASR agreement under $150M buyback program authorized in Jan 2024; $35M paid to Jefferies.
- Initial delivery of 888,889 shares based on $31.50 closing price on May 10, 2024 (~80% of expected total).
- Final number determined by VWAP during ASR term; settlement expected Q3 2024.
- As of March 31, 2024, outstanding shares ~32.7M, implying initial delivery covers ~2.7% of shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465924060235/0001104659-24-060235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465924060235/tm2414016d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-060235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer